H. Deckx

Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects

JB Vanderpas, Bernard Contempré, NL Duale et al. · American Journal of Clinical Nutrition · 1993 · 76 citations

Medicine, Endocrinology, Nutritional Sciences +14

Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials

Pablo Tebas, Michael Sension, José Ramón Arribas et al. · Clinical Infectious Diseases · 2014 · 63 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies

Mark Nelson, Richard Elion, C Cohen et al. · HIV Clinical Trials · 2013 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

Thomas J. Schnitzer, María Pueyo, H. Deckx et al. · Osteoarthritis and Cartilage · 2023 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Change in Vitamin D Levels and Risk of Severe Vitamin D Deficiency over 48 Weeks among HIV-1-Infected, Treatment-Naive Adults Receiving Rilpivirine or Efavirenz in a Phase III Trial (Echo)

David A. Wohl, Chloe Orkin, Manuela Doroana et al. · Antiviral Therapy · 2013 · 40 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17